UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

Photo of Lee Jackson
By Lee Jackson Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

The UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health care. Given that health care has outperformed significantly year to date, hedge funds that are “lightening up” on health care exposure could signal a year-end rotational move. The hedge funds could be coming out of the high-flying stocks and sectors and into underperformers. Credit Suisse recently reported hedge fund rotation out of high flyers in to international stocks. The top funds have also continued to flow into the energy sector despite falling oil prices.

Hedge funds are moving their money toward the financial names that are benefiting from the slow but sure economic expansion. They also are placing bets on the stocks that continue to benefit from strong equity market gains and an increasingly robust investment banking sector. The stocks seeing the most interest may include Citigroup Inc. (NYSE: C), Morgan Stanley (NYSE: MS), Goldman Sachs Group Inc. (NYSE: GS), Bank of America Corp. (NYSE: BAC) and J.P. Morgan Chase & Co. (NYSE: JPM).

Hedge funds flows are also going toward the energy sector, despite crude prices that fallen to their lowest levels in almost a year. The rationale for the rotation appears to be a belief that energy companies are ready to challenge the restrictions on crude exports after huge increases in domestic production. They may argue that limits designed to keep petroleum in America may violate international trade rules. The top energy names seeing interest from hedge funds may include Exxon Mobil Corp. (NYSE: XOM), Chevron Corp. (NYSE: CVX), Pioneer Natural Resources Co. (NYSE: PXD), Occidental Petroleum Corp. (NYSE: OXY), EOG Resource Inc. (NYSE: EOG) and Anadarko Petroleum Corp. (NYSE: APC). Oil Services giants Schlumberger Ltd. (NYSE: SLB) and Halliburton Co. (NYSE: HAL) may also be attracting hedge fund inflows.

The top biotech and health care names that could see selling pressure are the momentum stocks and large cap leaders that have seen huge gains this year. They include Biogen Idec Inc. (NASDAQ: BIIB), Regeneron Pharmaceuticals Inc. (NYSE: REGN), Amgen Inc. (NASDAQ: AMGN) and smaller names like Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) and Medivation Inc. (NASDAQ: MDVN).

The stock market rally, especially in the technology names, is starting to draw comparisons to the rally of 1999, which ultimately led to a tech bust and disaster. The difference this time, which is always a no-no on Wall Street, is valuations. The S&P 500 is currently trading at about 16 times forward earnings. That number is way up from the 2009 trough, but nowhere near bubble territory. The top portfolio managers at hedge funds are making bets that the market rally could continue, even if a sizable correction is tossed in. By rotating to names that are more reasonable, they may be set up to catch a continuation of the rally in 2014.

Photo of Lee Jackson
About the Author Lee Jackson →

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad and diverse career, which included a stint as the creative services director at the NBC affiliate in Austin, Texas, gives him unique insight into the financial industry and world.

Lee Jackson's journey in the financial industry spans over 30 years, with nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career was marked by his presence on the sell side during pivotal Wall Street events, from the dot.com rise and bubble to the Long Term Capital Management debacle, 9/11, and the Great Recession of 2008. This is a testament to his resilience and adaptability in the face of market volatility.

Lee Jackson’s practical financial industry experience, acquired from a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing on various platforms. This unique combination allows him to shed light on the intricacies and workings of Wall Street in a way that only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618